title: [Comorbidity of tics and stuttering].
abstract: OBJECTIVE
  To determine the clinical presentations of stuttering in children with tics treated with noofen.
  
  
  METHODS
  Authors examined 181 children with tics, aged 7-13. Stuttering was identified in 23.2% of cases. Thirty children with tics and comorbid stuttering received noofen. RESULTS AND СONCLUSION: The prevalence of stuttering in children with tics was significantly higher than in the population. Stuttering was significantly more frequent in children with transient tics than chronic tics. Neurotic stuttering was recorded more frequently. The high efficacy of noofen was shown; the decrease in ticks was obtained in 80% of cases, the reduction of stuttering in 66.7% of cases. The data of clinical, psychological and neurophysiological studies, confirming the improvement of patients after treatment, are presented.
authors.forename: S Yu
authors.initials: SY
authors.lastname: Surushkina
authors.forename: L S
authors.initials: LS
authors.lastname: Chutko
authors.forename: K A
authors.initials: KA
authors.lastname: Aitbekov
authors.forename: I S
authors.initials: IS
authors.lastname: Nikishena
authors.forename: Yu I
authors.initials: YI
authors.lastname: Bondarchuk
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000627:therapeutic use; D002648:Child; D015897:Comorbidity; D005260:Female; D006801:Humans; D008297:Male; D013342:Stuttering / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D020323:Tics / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; C008842:4-amino-3-phenylbutyric acid